ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750395 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750395; 2) Community: the network communities that were significantly associated with the response to NSC 750395; 3) Molecule: the relationships between components within communities and NSC 750395; 4) MDR: the compounds that were significantly associated with the NSC 750395.

NSC Compound Enrichment Correlation
NSC 710549 Null 0.0202245331784479 0.25390982
NSC 714379 Null 0.0202245331784479 0.27504508
NSC 719715 Null 0.0202245331784479 0.32100108
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0202245331784479 0.24791666
NSC 720447 Null 0.0202245331784479 -0.26427158
NSC 721049 7Z-Plakortide H 0.0202245331784479 0.20553804
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0202245331784479 0.47591924
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0202245331784479 0.091773854
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0202245331784479 0.31182521
NSC 740 Methotrexate 0.0202245331784479 0.46840634
Total:111  Current:61    [First] [Prev] [Next] [Last]